MIND C.T.I. (NASDAQ: MNDO) faces Nasdaq $1 bid-price deficiency deadline
Rhea-AI Filing Summary
MIND C.T.I. Ltd. reported that it received a Nasdaq notice on June 23, 2026 stating it no longer meets the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1), after its ordinary shares closed below $1 for 30 consecutive business days from May 8 to June 22, 2026.
The company has 180 calendar days, until December 21, 2026, to regain compliance, which can occur if the closing bid is at least $1 for ten consecutive business days or through a reverse stock split completed at least ten business days before that date. The shares remain listed and trading on Nasdaq under symbol “MNDO” during this period, but failure to cure the deficiency could ultimately lead to delisting.
Positive
- None.
Negative
- Nasdaq minimum bid deficiency and delisting risk: MIND C.T.I. no longer meets Nasdaq’s $1 minimum bid price rule after 30 consecutive trading days below $1, creating a defined 180-day cure window and potential future delisting if compliance is not regained.
Insights
Nasdaq bid-price deficiency raises listing risk for MIND C.T.I.
MIND C.T.I. Ltd. has fallen out of compliance with Nasdaq’s $1 minimum bid rule after 30 straight days below that level. The company now has a 180-day window, ending December 21, 2026, to restore its share price.
Compliance can be regained if the closing bid reaches at least $1 for ten consecutive business days or via a reverse stock split completed ten business days before the deadline. Both paths focus on price, not fundamentals, so underlying business performance remains a separate question.
If compliance is not restored and no extension is granted, Nasdaq may proceed toward delisting, which typically shifts trading to less liquid markets. Investors relying on a Nasdaq listing should pay particular attention to any future company actions on price compliance before the December 21, 2026 deadline.
Key Figures
Key Terms
Minimum Bid Price Requirement regulatory
Nasdaq Listing Rule 5450(a)(1) regulatory
reverse stock split financial
Compliance Period regulatory
delisting regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.